MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
暂无分享，去创建一个
Richard W. Martin | M. Mayes | M. Baron | R. Simms | V. Steen | L. Chung | V. Hsu | B. Kahaleh | J. Pope | N. Sweiss | L. Shapiro | D. Fiorentino | F. Wigley | J. Shanahan | N. Rothfield | Edwin A. Smith | B. Gruber | S. Sule | D. Collier | M. Csuka | A. Gilbert | F. Dechow | J. Gregory